Patients admitted with an acute coronary syndrome in New Zealand in 2007: Results of a second comprehensive nationwide audit and a comparison with the first audit from 2002

New Zealand Medical Journal

Volumn 123, Issue 1319, 2010, Pages

  Ellis, Chris ^a   Gamble, Greg ^b   Hamer, Andrew ^c   Williams, Michael ^g   Matsis, Philip ^e   Elliott, John ^f   Devlin, Gerard ^d   Richards, Mark ^h   White, Harvey ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c NELSON HOSPITAL   (New Zealand)

^d WAIKATO HOSPITAL   (New Zealand)

^e WELLINGTON HOSPITAL   (New Zealand)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

^g DUNEDIN HOSPITAL   (New Zealand)

^h UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE MANAGEMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEW ZEALAND; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

EID: 77955117903     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. New Zealand Health Information Service. Mortality and demographic Data 2004. http://www.nzhis.govt.nz/moh.nsf/indexns/stats
2. Bassand J, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of cardiology. Eur Heart J 2007;28:1598-1660. (Pubitemid 47227122)
3. Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of cardiology. Eur Heart J 2008;29:2909-2945.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary. J Am Coll Cardiol 2007;50:652-726.
5. Antman EM, Hand M, Armstrong PW et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2008;51:210-247.
6. Non ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. Non ST-elevation myocardial infarction: New Zealand management guidelines. NZ Med J 2005;118:1-19. http://www.nzma.org.nz/journal/118-1223/1680
7. ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-elevation myocardial infarction: New Zealand management guidelines. NZ Med J 2005;118 (1223). http://www.nzma.org.nz/journal/118-1223/1679
8. Ellis C, Gamble G, French J et al. Management of patients admitted with an Acute Coronary Syndrome in New Zealand: Results of a comprehensive nationwide audit. NZ Med J 2004;117(1197). http://www.nzma.org.nz/journal/117-1197/953
9. Ellis C, Devlin G, Matsis P, et al. Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. NZ Med J. 2004;117(1197). http://www.nzma.org.nz/journal/ 117-1197/954
10. Elliott J, Richards M. Heart attacks and unstable angina (acute coronary syndromes) have doubled in New Zealand since 1989: how do we best manage the epidemic? NZ Med J 2005;118(1223). http://www.nzmj.com/journal/118-1223/1674
11. Devlin G, Anderson FA, Heald S, et al. Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry. Heart 2005; doi: 10.1136/hrt.2004.054007.
12. White H, Ellis C. PHARMAC and lack of funding for clopidogrel. NZ Med J 2006;119(1228). http://www.nzma.org.nz/journal/119-1228/1808
13. Ellis C, White H. PHARMAC and the statin debacle. NZ Med J 2006;119(1236). http://www.nzma.org.nz/journal/119-1236/2003
14. Tang WT, Wong C, Herbison P. Community hospital versus tertiary hospital comparison in the treatment and outcome of patients with acute coronary syndrome: a New Zealand experience. NZ Med J 2006;119:1238. http://www.nzma.org. nz/journal/119-1238/2078 (Pubitemid 44144878)
15. Williams M. Percutaneous coronary intervention in New Zealand. NZ Med J 2007;120:1248. http://www.nzma.org.nz/journal/120-1248/2398
16. White HD. Systems of care. Need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fribrinolysis. Circulation 2008;118:219-222.
17. Ellis CJ, Gamble GD. Seasonal influence on death from ischaemic heart disease: Data from the Southern hemisphere. NZ Med J 2002;115(1162). http://www.nzma.org.nz/journal/115-1162/194
18. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2007;50:2173-2195.
19. Hockman JS, Sleeper LA, Webb JG, et al. Early revascularisation in acute myocardial infarction complicated by cardiogenic shock. N Eng J Med 1999;341:625-634.
20. Latif M, Chataline A, Gamble G, et al Different analysers and variable thresholds with troponin testing in New Zealand 2002-2007: is it time for some National standardization? Heart Lung and Circulation 2008;17(2):15.
21. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction. A comprehensive review of contemporary management options. J Am Coll Cardiol 2007;50:917-929.
22. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-2293.
23. Chew D, Amerena J, Coverdale S, et al. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Int Med J 2007;37:741-748.
24. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-Elevation acute coronary syndromes. Insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines). Circ 2005;111:1225-1232.
25. Fox KAA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297 1892-1900.
26. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
27. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001:345:528-532.
28. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA. 2002;288:2411-20.
29. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Eng J Med. 2005;352:1179-1189.
30. Ellis CJ, Hamer AW. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond. NZ Med J 2008;121(1269):5-10. http://www.nzma.org.nz/journal/121-1269/2927
31. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372:570-584.
32. Gorman D, Scott J. New Zealand's health system is subject to government rather than governance: inadequate representation of doctors in the health system elite. NZ Med J 2008;121(1276). http://www.nzma.org.nz/journal/121-1276/ 3113
33. Wong C, Tang EW, Herbison P. Survival over 5 years in the initial hospital survivors with acute coronary syndrome: a comparison between a community hospital and a tertiary hospital in New Zealand. NZ Med J 2007;120(1261). http://www.nzma.org.nz/journal/120-1261/2713
34. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-1920.
35. Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-749. (Pubitemid 38222894)
36. Chew D, White HD. Myocardial Infarction Mortality-Where do we go now? European Cardiovascular Disease 2007; Issue 1:33-34.
37. Carlhed R, Bojestig M, Wallentin L, et al. Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. Am Heart J 2006;152:1175-1181.
38. Mark DB, Van de Werf FJ, Simes RJ, et al. Cardiovascular disease on a global scale: defining the path forward for research and practice. Eur Heart J 2007;28:2678-2684.
39. Schiele F, Meneveau N, Seronde MF, et al. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart Journal 2005;26:873-880.
40. Scott IA, Denaro CP, Hickey AC, et al. Optimising care of acute coronary syndromes in three Australian hospitals. Int J of Quality in Health Care 2004;4:275-284. (Pubitemid 39157538)